We are live on ! Find out more
Xponance

Xponance Portfolio holdings

AUM $16.3B Turnover 12.69%
1-Year Est. Return 44.61%
This Fund
S&P 500
This Quarter Est. Return
+6.44%
1 Year Est. Return
+44.61%
3 Year Est. Return
+143.93%
5 Year Est. Return
+195.59%
10 Year Est. Return
+501.04%
AUM
$10.4B
AUM Growth
+$576M
Cap. Flow
+$80.3M
Cap. Flow %
0.78%
Top 10 Hldgs %
38.6%
Holding
1,407
New
91
Increased
858
Reduced
433
Closed
18
Avg Time Held
3.1 years
Top 10 Avg Time Held
3.3 years
Top 20 Avg Time Held
2.8 years

Top Buys

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$12.5M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$12.5M
3
META icon
Meta Platforms (Facebook)
META
+$8.69M
4
V icon
Visa
V
+$8.21M
5
AMZN icon
Amazon
AMZN
+$6.1M

Sector Composition

Rank Sector Weight
1 Technology 35.83%
2 Consumer Discretionary 11.41%
3 Financials 11.04%
4 Healthcare 10.64%
5 Communication Services 9.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
AGCO icon
701
AGCO
AGCO
$7.43B
$998K 0.01%
10,201
+891
+10% +$83K
2020 Q2
17 quarters
FCN icon
702
FTI Consulting
FCN
$4.05B
$997K 0.01%
4,381
+366
+9% +$81.3K
2020 Q2
17 quarters
HALO icon
703
Halozyme
HALO
$13.8B
$996K 0.01%
17,403
-359
-2% -$20.6K
2020 Q4
15 quarters
VOYA icon
704
Voya Financial
VOYA
$8.56B
$985K 0.01%
12,431
-116
-0.9% -$8.28K
2021 Q4
11 quarters
ARW icon
705
Arrow Electronics
ARW
$11B
$985K 0.01%
7,413
+605
+9% +$76.7K
2020 Q2
17 quarters
EGP icon
706
EastGroup Properties
EGP
$10.4B
$982K 0.01%
5,257
+106
+2% +$19.5K
2019 Q2
21 quarters
PRI icon
707
Primerica
PRI
$8.63B
$980K 0.01%
3,695
-25
-0.7% -$6.31K
2020 Q2
17 quarters
HLI icon
708
Houlihan Lokey
HLI
$8.86B
$973K 0.01%
6,158
+221
+4% +$33K
2021 Q2
13 quarters
INGR icon
709
Ingredion
INGR
$6.19B
$968K 0.01%
7,040
-32
-0.5% -$4.07K
2020 Q2
17 quarters
GPK icon
710
Graphic Packaging
GPK
$2.56B
$967K 0.01%
32,694
-875
-3% -$24.9K
2021 Q2
13 quarters
GME icon
711
GameStop
GME
$14B
$965K 0.01%
42,092
+12,818
+44% +$293K
2021 Q2
13 quarters
RGEN icon
712
Repligen
RGEN
$11.7B
$964K 0.01%
6,480
-2,525
-28% -$362K
2020 Q2
17 quarters
ANF icon
713
Abercrombie & Fitch
ANF
$6.45B
$963K 0.01%
6,881
+3,700
+116% +$563K
2023 Q4
3 quarters
ORI icon
714
Old Republic International
ORI
$9.29B
$961K 0.01%
27,122
-1,053
-4% -$35.6K
2020 Q2
17 quarters
PARA icon
715
DELISTED
Paramount Global Class B
PARA
$958K 0.01%
90,164
+10,758
+14% +$117K
2020 Q2
17 quarters
DCI icon
716
Donaldson
DCI
$10B
$957K 0.01%
12,981
+21
+0.2% +$1.52K
2020 Q2
17 quarters
ITCI icon
717
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$950K 0.01%
12,981
-348
-3% -$26.2K
2022 Q1
10 quarters
SMAR icon
718
DELISTED
Smartsheet Inc.
SMAR
$950K 0.01%
17,153
+188
+1% +$9.11K
2020 Q2
17 quarters
HQY icon
719
HealthEquity
HQY
$7.64B
$946K 0.01%
11,558
-43
-0.4% -$3.32K
2020 Q2
17 quarters
SSD icon
720
Simpson Manufacturing
SSD
$7.14B
$946K 0.01%
4,944
+99
+2% +$17.8K
2020 Q4
15 quarters
SAIC icon
721
Saic
SAIC
$5.59B
$943K 0.01%
6,770
+522
+8% +$65.9K
2020 Q2
17 quarters
RPRX icon
722
Royalty Pharma
RPRX
$26.7B
$942K 0.01%
33,294
+1,590
+5% +$44K
2020 Q4
15 quarters
CVLT icon
723
Commault Systems
CVLT
$6.47B
$933K 0.01%
6,064
-307
-5% -$43.2K
2020 Q2
17 quarters
RBC icon
724
RBC Bearings
RBC
$15.9B
$929K 0.01%
3,102
+5
+0.2% +$1.44K
2021 Q2
13 quarters
ESNT icon
725
Essent Group
ESNT
$5.7B
$919K 0.01%
14,296
+48
+0.3% +$2.94K
2020 Q2
17 quarters

Similar funds

Xponance's Q3 2024 Portfolio in Review

As of Q3 2024, Xponance held 1,407 positions worth $10.4B, up 5.9% from $9.78B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Xponance's Q3 2024 filing shows 91 new, 858 increased, 433 reduced and 18 closed positions. Its largest new stake was Smurfit Westrock: 106,066 shares worth $5.24M. The largest sale was Eli Lilly, an estimated $7.31M.

By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 37% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Xponance's largest Q3 2024 buy was Smurfit Westrock: 106,066 shares worth $5.24M.
  • Xponance added most to Broadcom in Q3 2024, an estimated $12.5M increase.
  • Xponance's biggest Q3 2024 reduction was Eli Lilly, cutting an estimated $7.31M.
  • Xponance fully exited Invesco S&P 500 Concentrated QVM ETF in Q3 2024, selling an estimated $3.61M.
  • Xponance's ten largest holdings make up 39% of its $10.4B portfolio in Q3 2024.
  • Xponance opened 91 new positions and closed 18 in Q3 2024.
  • Xponance's portfolio value rose 5.9% quarter-over-quarter to $10.4B.

Based on Xponance's 13F filing for Q3 2024, filed 12 Nov 2024.